Chlorambucil in Behcet's disease. A reappraisal

K. F. Tabbara

Research output: Contribution to journalArticlepeer-review

53 Scopus citations


Ten patients with Behcet's disease were treated with chlorambucil alone. At the therapeutic drug level of 0.2 mg/kg, seven patients developed oligospermia and three patients developed azoospermia. A 30-year-old patient underwent a testicular biopsy two years after the cessation of therapy. Histopathology revealed evidence of testicular atrophy. Fifteen (75%) out of 20 eyes had a visual acuity of 20/200 or less following therapy. It is concluded that chlorambucil should not be used as the first line of therapy in Behcet's disease and that its long term benefits in patients with Behcet's disease should be reevaluated.

Original languageEnglish (US)
Pages (from-to)906-908
Number of pages3
Issue number8
StatePublished - 1983
Externally publishedYes

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Chlorambucil in Behcet's disease. A reappraisal'. Together they form a unique fingerprint.

Cite this